国新健康：预计2025年全年扣除后营业收入:35,077万元

Core Viewpoint - Guoxin Health has released a performance forecast, expecting a total operating revenue of 350.77 million yuan for the year 2025, with a focus on health data and digital transformation in the healthcare sector [1] Group 1: Performance Forecast - The company anticipates an operating revenue of approximately 350.77 million yuan for 2025 [1] - The net profit attributable to shareholders is expected to be around -409 million yuan [1] Group 2: Financial Performance - For the first three quarters of 2025, the company's main revenue was 170 million yuan, a year-on-year decrease of 14.87% [2] - The net profit attributable to shareholders for the same period was -138 million yuan, a year-on-year decline of 347.32% [2] - The company's gross profit margin was reported at -5.15% [2] Group 3: Quarterly Performance - In Q3 2025, the company's single-quarter main revenue was 74.87 million yuan, an increase of 19.26% year-on-year [2] - The net profit attributable to shareholders for Q3 was -39.34 million yuan, a year-on-year decrease of 193.59% [2] - The company reported a debt ratio of 37.02% and investment income of 16.57 million yuan [2] Group 4: Reasons for Performance Changes - The increase in losses is primarily due to expected impairment of trading financial assets, particularly related to Shenzhou Medical Technology Co., Ltd., which has seen a decline in operating performance [1]